Abiomed To Show AbioCor Is Safe Enough For Healthier Patients
This article was originally published in The Gray Sheet
Executive Summary
Abiomed is developing a smaller version of its artificial heart for the 65% of patients whose chest size is not large enough to accommodate the AbioCor device. The company recently began testing the Penn State Heart in animals and expectshuman implants to begin in 2004